A prophylactic subcutaneous dose of the anticoagulant tinzaparin does not influence qPCR-based assessment of circulating levels of miRNA in humans.
Nilsson A, Nerhall AM, Vechetti I, Fornander L, Wiklund S, Alkner B, Schilcher J, von Walden F.
PLoS One. 2022 Nov 3;17(11):e0277008. doi: 10.1371/journal.pone.0277008. eCollection 2022.
PMID:36327247
Relationship between ex vivo anti-proteinase (factor Xa and thrombin) assays and in vivo anticoagulant effect of very low molecular weight heparin, CY222.
Tew CJ, Lane DA, Thompson E, Ireland H, Curtis JR.